{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:54:52Z","timestamp":1785218092401,"version":"3.55.0"},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,11,30]]},"DOI":"10.18632\/aging.205216","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:44:02Z","timestamp":1700246642000},"page":"13010-13040","source":"Crossref","is-referenced-by-count":4,"title":["Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Jinyan","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"},{"name":"Department of Orthopedics, Affiliated Hospital of Chifeng University, Chifeng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China"},{"name":"Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma.","volume":"7","author":"Finn","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10552-020-01386-x","article-title":"Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.","volume":"3","author":"Thrift","year":"2021","journal-title":"Cancer Causes Control"},{"key":"4","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.7150\/ijbs.45050","article-title":"A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.","volume":"1","author":"Li","year":"2020","journal-title":"Int J Biol Sci"},{"key":"5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12885-021-07808-6","article-title":"Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients.","volume":"2","author":"Xiang","year":"2021","journal-title":"BMC Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.6004\/jnccn.2017.7024","article-title":"Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.","volume":"1","author":"Abou-Alfa","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.31673","article-title":"H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha\/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p.","volume":"7","author":"Zhang","year":"2021","journal-title":"Hepatology"},{"key":"8","doi-asserted-by":"publisher","first-page":"12131","DOI":"10.1073\/pnas.2001760117","article-title":"Topoisomerase II\u03b1 is essential for maintenance of mitotic chromosome structure.","volume":"11","author":"Hudson","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12935-019-0956-1","article-title":"Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.","volume":"1","author":"Wang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10","doi-asserted-by":"publisher","first-page":"e2114024119","DOI":"10.1073\/pnas.2114024119","article-title":"Recurrent mutations in topoisomerase II\u03b1 cause a previously undescribed mutator phenotype in human cancers.","volume":"11","author":"Rozen","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41422-020-0375-9","article-title":"Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.","volume":"3","author":"Kaklamani","year":"2021","journal-title":"Cell Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2147\/CMAR.S240577","article-title":"TOP2A Promotes Cell Migration, Invasion and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating the PI3K\/AKT Signaling.","volume":"1","author":"Huang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2021.06.069","article-title":"MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells.","volume":"57","author":"Wu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cam4.2743","article-title":"Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients.","volume":"9","author":"Milanowski","year":"2020","journal-title":"Cancer Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"681388","DOI":"10.3389\/fmed.2021.681388","article-title":"A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma.","volume":"8","author":"Jiang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/ncb3467","article-title":"Lnc-ing ROR1-HER3 and Hippo signalling in metastasis.","volume":"1","author":"Kang","year":"2017","journal-title":"Nat Cell Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.2503","article-title":"Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.","volume":"3","author":"Kim","year":"2015","journal-title":"J Bone Miner Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"689139","DOI":"10.3389\/fmolb.2021.689139","article-title":"Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications.","volume":"8","author":"Chen","year":"2021","journal-title":"Front Mol Biosci"},{"key":"19","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1111\/jcmm.15242","article-title":"Characterization of the prognostic values and response to immunotherapy\/chemotherapy of Kr\u00fcppel-like factors in prostate cancer.","volume":"2","author":"Liang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer.","volume":"4","author":"Paull","year":"2018","journal-title":"Immunity"},{"key":"21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy.","volume":"2","author":"Pardoll","year":"2015","journal-title":"Cancer Cell"},{"key":"22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma.","volume":"1","author":"Finn","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016.","volume":"2","author":"He","year":"2022","journal-title":"Journal of the National Cancer Center"},{"key":"24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma.","volume":"1","author":"Finn","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.","volume":"38","author":"Xu","year":"2020","journal-title":"N Engl J Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"2001961","DOI":"10.1002\/advs.202102956","article-title":"RNF219\/-Catenin\/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications.","volume":"8","author":"Mo","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/ijo.2020.5045","article-title":"ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.","volume":"5","author":"Dong","year":"2020","journal-title":"Int J Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-019-1044-9","article-title":"The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.","volume":"1","author":"Xiang","year":"2019","journal-title":"Mol Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1158\/1078-0432.CCR-17-0413","article-title":"TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.","volume":"2","author":"Schaeffer","year":"2017","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.7150\/jca.41415","article-title":"TOP2A Promotes Lung Adenocarcinoma Cells\u2019 Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma.","volume":"1","author":"Yang","year":"2020","journal-title":"J Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.7150\/jca.64017","article-title":"TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p.","volume":"1","author":"Xu","year":"2022","journal-title":"J Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo Pathway: Biology and Pathophysiology.","volume":"8","author":"Guan","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.","volume":"1","author":"Guan","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"34","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1002\/jcp.26372","article-title":"The emerging role of Hippo signaling pathway in regulating osteoclast formation.","volume":"23","author":"Qian","year":"2018","journal-title":"J Cell Physiol"},{"key":"35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ncb3464","article-title":"A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.","volume":"1","author":"Zhou","year":"2017","journal-title":"Nat Cell Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"ra12","DOI":"10.1126\/scisignal.aad3210","article-title":"ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.","volume":"9","author":"Pendergast","year":"2016","journal-title":"Sci Signal"},{"key":"37","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.","volume":"2","author":"Masaki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41423-020-00572-w","article-title":"Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.","volume":"1","author":"Greten","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"39","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1038\/s41388-020-1249-9","article-title":"Immune-based therapies for hepatocellular carcinoma.","volume":"3","author":"Rimassa","year":"2020","journal-title":"Oncogene"},{"key":"40","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1634\/theoncologist.2010-0358","article-title":"Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.","volume":"1","author":"Zhu","year":"2011","journal-title":"Oncologist"},{"key":"41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform.","volume":"3","author":"Haussler","year":"2020","journal-title":"Nat Biotechnol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/bioinformatics\/btx812","article-title":"TCGA-assembler 2: software pipeline for retrieval and processing of TCGA\/CPTAC data.","volume":"3","author":"Ji","year":"2018","journal-title":"Bioinformatics"},{"key":"43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project.","volume":"4","author":"GTEx Consortium","year":"2013","journal-title":"Nat Genet"},{"key":"44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","article-title":"The International Cancer Genome Consortium Data Portal.","volume":"3","author":"Ferretti","year":"2019","journal-title":"Nat Biotechnol"},{"key":"45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia.","volume":"18","author":"Rejtar","year":"2020","journal-title":"Cell"},{"key":"46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based Human Protein Atlas.","volume":"2","author":"Ponten","year":"2010","journal-title":"Nat Biotechnol"},{"key":"47","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.","volume":"7","author":"Liu","year":"2017","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions.","volume":"3","author":"Zhang","year":"2019","journal-title":"Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:33:24Z","timestamp":1701873204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":48,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,30]]}},"alternative-id":["205216","37980167"],"URL":"https:\/\/doi.org\/10.18632\/aging.205216","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}